These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 8446282)
1. Intraperitoneal infusion of dialysate: a possible cause of increased plasma atrial natriuretic peptide levels. Calzavara P; Da Rin G; Salandin V; Amici GP; Galardi N; Vianello A; Bocci C; da Porto A Nephron; 1993; 63(3):361-2. PubMed ID: 8446282 [No Abstract] [Full Text] [Related]
2. Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans. Fincher ME; Campbell HT; Sklar AH; Caruana RJ; Lightfoot BO; Cheek PL; Smith KL; Hess CP Adv Perit Dial; 1989; 5():16-9. PubMed ID: 2577402 [TBL] [Abstract][Full Text] [Related]
3. [Plasma levels of atrial natriuretic peptide and its relationship with arterial blood pressure before and after peritoneal dialysate infusion]. Calzavara P; Da Rin G; Galardi N; Amici G; Vianello A; Mordacchini M; Maresca MC; Bocci C Medicina (Firenze); 1990; 10(2):171-3. PubMed ID: 2148794 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study. Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828 [TBL] [Abstract][Full Text] [Related]
5. Effect of hemodialysis on plasma levels of vasoactive peptides: endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide. Niwa T; Fujishiro T; Uema K; Tsuzuki T; Tominaga Y; Emoto Y; Miyazaki T; Maeda K Nephron; 1993; 64(4):552-9. PubMed ID: 8366980 [TBL] [Abstract][Full Text] [Related]
6. Influence of intraperitoneal volume on QT dispersion in patients with continuous ambulatory peritoneal dialysis: acute cardiac impact of peritoneal dialysis. Kocak G; Azak A; Huddam B; Yalcin F; Güven B; Can M; Duranay M Ren Fail; 2011; 33(6):568-71. PubMed ID: 21631168 [TBL] [Abstract][Full Text] [Related]
7. Intravenous iron sucrose changes the intraperitoneal homeostasis. Breborowicz A; Połubinska A; Kupczyk M; Wanic-Kossowka M; Oreopoulos DG Blood Purif; 2009; 28(1):53-8. PubMed ID: 19325240 [TBL] [Abstract][Full Text] [Related]
8. Carcinogenic glutamic acid pyrolysis product in the dialysate of uremic patients treated by continuous ambulatory peritoneal dialysis. Yanagisawa H; Manabe S; Kanai Y; Wada O Clin Nephrol; 1988 Aug; 30(2):73-8. PubMed ID: 3052953 [TBL] [Abstract][Full Text] [Related]
9. Vasoactive hormones in uremic patients on continuous ambulatory peritoneal dialysis. Lai KN; Li PK; Woo KS; Lui SF; Leung JC; Law E; Nicholls MG Clin Nephrol; 1991 May; 35(5):218-23. PubMed ID: 1830251 [TBL] [Abstract][Full Text] [Related]
11. Malnutrition in continuous ambulatory peritoneal dialysis and use of intraperitoneal amino acids. Dombros NV; Digenis GE; Oreopoulos DG Contrib Nephrol; 1992; 100():188-206. PubMed ID: 1458902 [No Abstract] [Full Text] [Related]
12. Confirmation of dialysate leakage by intraperitoneal administration of radioactive colloid. Otsuka N; Kawai S; Fukunaga M; Ono S; Morita K; Nagai K; Tomomitsu T; Yanagimoto S; Mimura H; Ohsawa G Radiat Med; 1992; 10(6):253-5. PubMed ID: 1287737 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. IV. A large intraperitoneal dose of furosemide in the modeling of continuous peritoneal dialysis]. Grzegorzewska A Przegl Lek; 1988; 45(11):770-5. PubMed ID: 3244842 [No Abstract] [Full Text] [Related]
14. Plasma ANP and cGMP levels in CAPD patients. Lauster F; Heim JM; Drummer C; Gerzer R; Schiffl H Contrib Nephrol; 1993; 101():44-50. PubMed ID: 8385595 [No Abstract] [Full Text] [Related]
15. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Lin CY; Lin CC; Huang TP Nephron; 1993; 63(4):404-8. PubMed ID: 8459875 [TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis. Bald M; Bonzel KE; Rascher W Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis. Ando R; Matsuda O; Miyake S; Yoshiyama N Nephron; 1988; 50(3):225-8. PubMed ID: 2976122 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of atrial natriuretic peptide in chronically dialyzed patients. Deray G; Maistre G; Basset JY; Cacoub P; Carayon A; Anouar M; Baumelou A; Legrand JC; Ancri D; Jacobs C Kidney Int Suppl; 1988 Sep; 25():S86-8. PubMed ID: 2972869 [No Abstract] [Full Text] [Related]
20. Tuberculous peritonitis in a child undergoing continuous ambulatory peritoneal dialysis. Tsai TC; Hsu JC; Chou LH; Lee ML Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(5):455-9. PubMed ID: 7942034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]